Skip to main content
Home / International Journal of Oncology, Volume 3, Number 4
The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.

Publisher: Spandidos Publications

More about this publication?
Volume 3, Number 4, 1 October 1993

Articles

MOLECULAR EVENTS IN THE INITIATION AND PROGRESSION OF BLADDER-CANCER (REVIEW)
pp. 549-557(9)
Author: STADLER, WM

Favourites:
ADD

LOSS OF TELOMERIC DNA DURING AGING MAY PREDISPOSE CELLS TO CANCER (REVIEW)
pp. 559-563(5)
Authors: SHAY, JW; WRIGHT, WE; WERBIN, H

Favourites:
ADD

CHARACTERIZATION OF ECTOPICALLY-EXPRESSED ETS1 IN HUMAN COLON-CANCER CELLS - INDUCTION OF PUTATIVE ETS1-TARGET GENE
pp. 565-573(9)
Authors: SUZUKI, H; ROMANOSPICA, V; GEORGIOU, P; FISHER, RJ; PAPAS, TS; BHAT, N

Favourites:
ADD

HORMONE-VIRUS INTERACTION IN CARCINOGENESIS - A CLUE TO THE ETIOLOGY OF AIDS (REVIEW)
pp. 575-585(11)
Authors: KODAMA, M; KODAMA, T

Favourites:
ADD

PROLONGED PROLIFERATION OF PRIMARY CHICKEN-EMBRYO FIBROBLASTS TRANSFECTED WITH CDNAS FROM THE BAMHI-H GENE FAMILY OF MAREKS-DISEASE VIRUS
pp. 587-591(5)
Authors: PENG, FY; DONOVAN, J; SPECTER, S; TANAKA, A; NONOYAMA, M

Favourites:
ADD

DETECTION OF HEPATITIS-B VIRUS-DNA AND MUTATIONS IN K-RAS AND P53 GENES IN HUMAN HEPATOCELLULAR CARCINOMAS
pp. 593-596(4)
Authors: NIKOLAIDOU, A; LILOGLOU, T; MALLIRI, A; ERGAZAKI, M; TINIAKOS, G; TINIAKOS, D; SPANDIDOS, DA

Favourites:
ADD

GASTRIC-CARCINOMA DEVELOPING IN THE RECONSTRUCTED GASTRIC TUBE FOLLOWING ESOPHAGECTOMY - ANALYSIS OF 58 CASES
pp. 597-601(5)
Authors: KITAMURA, K; SUGIMACHI, K

Favourites:
ADD

EVALUATION OF PHAGOCYTIC-ACTIVITY IN NEOPLASTIC PATIENTS TREATED WITH SUBCUTANEOUS RECOMBINANT IL-2
pp. 603-606(4)
Authors: ABBATE, I; GUIDA, M; MUSCI, MD; CASAMASSIMA, A; LATORRE, A; ADDABBO, L; DRAGONE, CD; CATTEDRA, M; CORREALE, M; DELENA, M

Favourites:
ADD

UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA), A PROTEASE WITH CYTOKINE-LIKE ACTIVITY IN HUMAN HL-60 LEUKEMIC-CELL LINE
pp. 607-613(7)
Authors: BERDEL, WE; WILHELM, O; SCHMITT, M; MAURER, J; REUFI, B; VONMARSCHALL, Z; OBERBERG, D; GRAEFF, H; THIEL, E

Favourites:
ADD

RUBOXYL, A NEW NITROXYL DERIVATIVE OF DAUNORUBICIN - ACUTE TOXICITY AND ANTITUMOR EFFECT IN ANIMALS
pp. 615-618(4)
Authors: LEONETTI, C; ARONNE, T; KONOVALOVA, N; DIATCHKOVSKAYA, R; SHAPIRO, A; FRANCHI, F

Favourites:
ADD

USE OF RHEK-1 IMMORTALIZED HUMAN KERATINOCYTES FOR DETECTION OF INDUCED MUTATION AT THE HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE LOCUS
pp. 619-625(7)
Authors: ALLENHOFFMANN, BL; SCHLOSSER, SJ; RHIM, JS

Favourites:
ADD

DIFFERENT RATES OF DEGRADATION OF THE PROLIFERATION-ASSOCIATED NUCLEAR AND NUCLEOLAR ANTIGENS DURING APOPTOSIS OF HL-60 CELLS INDUCED BY DNA TOPOISOMERASE INHIBITORS
pp. 627-634(8)
Authors: GORCZYCA, W; ARDELT, B; DARZYNKIEWICZ, Z

Favourites:
ADD

CYTOGENETIC PROGRESSION AND PROGNOSIS IN ORAL-CARCINOMA - A DNA FLOW CYTOMETRIC STUDY ON 317 CASES
pp. 635-640(6)
Authors: HEMMER, J; SCHON, E

Favourites:
ADD

POSSIBLE ASSOCIATION OF NM23 GENE-EXPRESSION AND KI-RAS POINT MUTATIONS WITH METASTATIC POTENTIAL IN HUMAN PANCREATIC CANCER-DERIVED CELL-LINES
pp. 641-644(4)
Authors: YASUDA, D; IGUCHI, H; IKEDA, Y; NISHIMURA, S; STEEG, PS; MISAWA, T; NAWATA, H; KONO, A

Favourites:
ADD

MYTH OF TUMOR IMMUNOLOGY (REVIEW)
pp. 645-653(9)
Authors: CHIGIRA, M; ARITA, S; WATANABE, H

Favourites:
ADD

INTERACTIONS OF CARDIOVASCULAR DRUGS WITH THE CYTOTOXICITY INDUCED BY EPIRUBICIN AND IRRADIATION IN-VITRO
pp. 655-659(5)
Authors: JONSSON, O; HENRIKSSON, R; GRANKVIST, K

Favourites:
ADD

EVALUATION OF THE CYTOTOXICITY OF THE INDOLOQUINONE EO9 IN A HUMAN COLON ADENOCARCINOMA MODEL
pp. 661-666(6)
Authors: BIBBY, MC; CRONIN, BP; PHILLIPS, RM

Favourites:
ADD

SQUAMOUS-CELL CARCINOMA OF THE UPPER LIP - ANALYSIS OF 123 CASES
pp. 667-669(3)
Authors: CALABRESE, L; IONNA, F; TRADATI, N; PIZZI, N; MATTAVELLI, F; GRECO, M; ZURRIDA, S; CANTU, G

Favourites:
ADD

ANALYSIS OF PROTOONCOGENES IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK (SCCHN)
pp. 671-677(7)
Authors: VOLLING, P; JUNGEHULSING, M; STUTZER, H; DIEHL, V; TESCH, H

Favourites:
ADD

A NEW DERIVATIVE OF CAMPTOTHECIN, IRINOTECAN HYDROCHLORIDE (CPT-11) INDUCES PROGRAMMED CELL-DEATH IN LEUKEMIA-LYMPHOMA CELL-LINES
pp. 679-685(7)
Authors: HUANG, RW; TAKATSUKI, K; TSUDA, H

Favourites:
ADD

MELATONIN MODULATION OF ESTROGEN-RECEPTOR EXPRESSION IN MCF-7 HUMAN BREAST-CANCER CELLS
pp. 687-694(8)
Authors: MOLIS, TM; WALTERS, MR; HILL, SM

Favourites:
ADD

CA549 IMMUNOASSAY IN BREAST-TISSUE - COMPARISON WITH CA15.3 AND MCA
pp. 695-699(5)
Authors: GION, M; PLEBANI, M; MIONE, R; CAPITANIO, G; PENZO, C; MEO, S

Favourites:
ADD

IDENTIFICATION OF DNA BENDING REGION IN HUMAN C-MYC GENE
pp. 701-706(6)
Authors: NISHITA, Y; ARIGA, H; IGUCHIARIGA, SMM

Favourites:
ADD

THE LACK OF IMPACT OF TREATMENT TIME ON THE OUTCOME OF DEFINITIVE RADIOTHERAPY FOR CARCINOMA OF THE PROSTATE
pp. 707-711(5)
Authors: ANSCHER, MS; MONTANA, GS; DODGE, R; GAYDICA, EF; DEWHIRST, MW; PROSNITZ, LR

Favourites:
ADD

PATIENT-LIKE NUDE-MOUSE AND SCID-MOUSE MODELS OF HUMAN LUNG AND PLEURAL CANCER (REVIEW)
pp. 713-718(6)
Authors: ASTOUL, P; WANG, X; HOFFMAN, RM

Favourites:
ADD

IMPAIRED ACTIVATION OF TUMORICIDAL FUNCTION IN MACROPHAGES FROM MAMMARY-TUMOR BEARERS - THE ROLE OF IFN-GAMMA
pp. 719-727(9)
Authors: SOTOMAYOR, EM; CHENG, XF; FU, YX; HAWKINS, A; CALDERONHIGGINSON, C; LOPEZ, DM

Favourites:
ADD

INCREASED EXPRESSION OF C-MYC MESSENGER-RNA AND PROTEIN IN WALKER 256 CANCER-CELLS STIMULATED BY BONE-DERIVED CONDITIONED MEDIA AND BY TRANSFORMING-GROWTH-FACTOR-BETA (TGF-BETA)
pp. 729-734(6)
Authors: KOSTENUIK, PJ; ORR, FW; ARSENAULT, L; MILLARBOOK, W; SINGH, G

Favourites:
ADD

P53 EXPRESSION DURING MULTISTAGE HUMAN ORAL CARCINOGENESIS
pp. 735-739(5)
Authors: ZHANG, L; ROSIN, M; PRIDDY, R; XIAO, Y

Favourites:
ADD

IMMUNOLOGICALLY DEFINED SUBCLASSES OF THE GROWTH SUPPRESSOR PROTEIN P53 DETECTED WITH ANTIBODIES IN SERA FROM TUMOR PATIENTS
pp. 741-747(7)
Authors: HOHER, D; KARTARIUS, S; PORZSOLT, F; MONTENARH, M

Favourites:
ADD

BINDING OF ANTIBODIES TO DIFFERENT CD13 EPITOPES ON HUMAN MYELOID LEUKEMIC-CELLS
pp. 749-754(6)
Authors: RAZAK, K; COLLINS, PW; KELSEY, SM; NEWLAND, AC

Favourites:
ADD

PROGNOSTIC FACTORS IN PURGED MARROW FROM PATIENTS WITH NEUROBLASTOMA RECEIVING MYELOABLATIVE TREATMENT - TUMOR-CELL NUMBER, N-MYC PROTEIN, N-MYC GENE AMPLIFICATION AND RATE OF HEMATOLOGIC RECOVERY
pp. 755-761(7)
Authors: GAZITT, Y; CANTOR, A; HE, YJ; KOZA, S; COHEN, RJ; GRAHAMPOLE, J

Favourites:
ADD

INHIBITION OF PROLIFERATION, ACTIVATION AND FUNCTION OF HUMAN NATURAL-KILLER-CELLS IN-VITRO BY SECRETED PRODUCTS OF LOVO, A COLORECTAL-CANCER CELL-LINE
pp. 763-768(6)
Authors: JOHNSTON, DH; ALLEN, PD; NEWLAND, AC; WILLIAMS, NS

Favourites:
ADD

ABSENCE OF GERMLINE PROHIBITIN MUTATIONS IN EARLY-ONSET BREAST-CANCER
pp. 769-772(4)
Authors: TOKINO, T; DAVIDSON, N; HELZLSOUER, K; ZEHNBAUER, B; NAKAMURA, Y; VOGELSTEIN, B; SIDRANSKY, D

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content